Peripheral resistance vessel dysfunction in Marfan syndrome

American Heart Journal

Volumn 139, Issue 4, 2000, Pages 661-666

  Nakamura, Motoyuki ^a   Itoh, Shigehiro ^b   Makita, Shinji ^b   Ohira, Atsushi ^b   Arakawa, Naoshi ^b   Hiramori, Katsuhiko ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASODILATOR AGENT;

ADULT; AORTA DISSECTION; AORTA ROOT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; GENE MUTATION; HUMAN; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034074386     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90045-0     Document Type: Article

References (20)

1. 1. Dietz HC, Cutting GR, Pyeritz RE, et al. Morfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337-9.
2. 2. Kainulainen K, Pulkkinen L, Savolainen A, et al. Location on chromosome 15 of the gene defect causing Marfan syndrome. New Engl J Med 1990;323:935-9.
3. 3. Aoyama T, Tynan K, Dietz HC, et al. Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. Hum Mol Genet 1993;2:2135-40.
4. 4. Davis EC. Immunolocalization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta. J Cell Sci 1994;107:727-36.
5. 5. Reinhardt DP, Chalberg SC, Sakai LY. The structure and function of fibrillin. Ciba F Symp 1995;192:128-43.
6. 6. Nichols WW, O'Rourke MF. Wave reflections. In: Nichols WW, O'Rourke MF, editors. McDonald's blood flow in arteries, theoretical, experimental and clinical principles. London: Arnold; 1998. p. 201-22.
7. 7. Yin FC, Brin KP, Ting CT, et al. Arterial hemodynamic indexes in Marfan's syndrome. Circulation 1989;79:854-62.
8. 8. Wilson DG, Bellamy MF, Ramsey MW, et al. Endothelial function in Marfan syndrome. Selective impairment of flow-mediated vasodilation. Circulation 1999;99:909-15.
9. 9. Beighton P, De Paepe A, Hall JG, et al. Molecular nosology of heritable disorders of connective tissue. Am J Med Genet 1992;42:431-48.
10. 10. Hirooka Y, Imaizumi T, Tagawa T, et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90:658-68.
11. 11. Nakamura M, Chiba M, Ueshima K, et al. Impaired cholinergic peripheral vasodilation and its relationship to hyperemic calf blood flow response and exercise intolerance in patients with chronic heart failure. Int J Cardiol 1995;48:139-46.
12. 12. Pedrinelli R, Spessot M, Chiriatti G, et al. Evidence for a systemic defect of resistance-sized arterioles in hypertrophic cardiomyopathy. Coron Art Dis 1993;4:67-72.
13. 13. Sparks HV Jr, Belloni FL. The peripheral circulation: local regulation. Ann Rev Physiol 1978;40:67-92.
14. 14. Rosei EA, Rizzoni D, Castellano M, et al. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertension 1995;13:341-7.
15. 15. Hirata K, Triposkiadis F, Sparks E, et al. The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol 1991;18:57-63.
16. 16. Jeremy RW, Huang H, Hwa J, et al. Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am J Cardiol 1994;74:369-73.
17. 17. Adams JN, Brooks M, Redpath TW, et al. Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan's syndrome. Br Heart J 1995;73:265-9.
18. 18. Nakamura M, Funakoshi T, Yoshida H, et al. Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers. J Cardiovasc Pharm 1992;20:949-54.
19. 19. Taddei S, Virdis A, Ghiadoni L, et al. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension 1997;30:1606-12.
20. 20. Green DJ, O'Driscoll JG, Blanksby BA, et al. Effect of casting on forearm resistance vessels in young men. Med Sci Sport Exer 1997;29:1325-31.